MedPath

MET-PET-study - A comparative study of Tc-99m- sestamibi SPECT/ldCT and C-11-L-Methionin PET/diagnostic CT and their ability to locate paratyroid adenomas preoperatively.

Phase 1
Conditions
Preoperative localisation of hyperfunctioning parathyroid tissue in suspected primary hyperparathyroidism.
MedDRA version: 19.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismSystem Organ Class: 100000004860
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
Registration Number
EUCTR2013-004886-14-DK
Lead Sponsor
Dep. Nuclear medicine, Odense university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Men and women above the age of 18 years who are referred to our department for preoperative localisation of hyperfunctioning parathyroid tissue prior to operation for suspected primary hyperparathyroidism.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Suspected secondary and tertiary hyperparathyroidism.
Suspected Familiar hypocalciuria hypercalcemia.
Suspected Familiar Hyperparathyroidism.
Suspected multiple endocrine neoplasia (MEN)
Patients treated with Lithium and / or Mimpara
Pregnancy.
Known allergy to the tracers infused.
Known allergy to iodine containing contrast agents.
Persons 18 years or younger.
Former operation / radiotherapy towards the neck.
If the prathyroidscintigraphy is cancelled or there is more than a forthnight between the two examniations.
If the patient has undergone operation between the two examinations.
If the patient is not operated within 12 months after completing the two examinations.
Inhability - if the person does not speak and understand danish to a degree acceptable to participate or has cognitive problems that complicates active participation.
If there is no signed consent to participate or the concent has been withdrawn.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath